Department of General Surgery, Section of Colon and Rectal Surgery, Vanderbilt University Medical Center, 1161 21st Ave South, Room D5248 MCN, Nashville, TN, 37232, USA.
Tech Coloproctol. 2019 Apr;23(4):325-332. doi: 10.1007/s10151-019-01951-w. Epub 2019 Apr 23.
The aim of the present study was to evaluate patient factors that affect the progression of anal dysplasia in human immunodeficiency virus (HIV)-positive individuals.
A retrospective cohort study of HIV-positive adults with human papilloma virus related anal lesions was performed from 2012 to 2017. All patients underwent surgical excision or biopsy and fulguration of lesions in the operating room without using high resolution anoscopy. Patients with initial presentation of squamous cell carcinoma were excluded. The study was designed to investigate progression between the first available histology and either the follow up histology or a negative examination. Patient files were reviewed and data was collected. A bivariate analysis of continuous and categorical variables was performed.
One hundred and sixty-one patients met the inclusion criteria. Ninety-seven percent were male. Mean age was 41 years. Thirty-five percent were African American and 47% were Caucasian. After a median follow-up interval of 331 days (IQR 120-615 days) 14 (9%) of patients had progression of disease. Visible lesions on initial presentation, as opposed to lesions found in patients undergoing examination under anesthesia because of HSIL on anal pap smear, was associated with progression (p = 0.0.2). A lower initial CD4 count (p = 0.01) and initial surgical pathology of anal condylomata (p = 0.01) were also associated with progression. High-risk serotype was associated with no change or regression (p = 0.01).
In our large cohort of HIV-positive patients treated without high resolution anoscopy the rate of progression was low. Most notably, visible lesions at initial presentation and CD4 count when lower were associated with progression. Initial surgical pathology of anal condylomata was associated with progression, while high-risk serotypes correlated with regression or stability. Identification of risk factors has important implications concerning postoperative surveillance and counseling of HIV-positive patients with anal condylomata/ anal dysplasia.
本研究旨在评估影响人类免疫缺陷病毒(HIV)阳性个体肛门发育不良进展的患者因素。
对 2012 年至 2017 年间患有 HPV 相关肛门病变的 HIV 阳性成年人进行了一项回顾性队列研究。所有患者均在手术室接受了手术切除或活检,并对病变进行了电灼,而无需使用高分辨率肛门镜。排除了初次表现为鳞状细胞癌的患者。本研究旨在调查首次可获得的组织学与随访组织学或阴性检查之间的进展情况。对患者的病历进行了回顾,并收集了数据。对连续和分类变量进行了双变量分析。
符合纳入标准的患者共 161 名。97%为男性,平均年龄为 41 岁。35%为非裔美国人,47%为白种人。中位随访间隔 331 天(IQR 120-615 天)后,14 名(9%)患者的疾病进展。与因肛门巴氏涂片 HSIL 而接受麻醉下检查的患者相比,初次就诊时出现可见病变(p=0.02)与疾病进展相关。初始 CD4 计数较低(p=0.01)和初始肛门湿疣的外科病理学(p=0.01)也与进展相关。高危血清型与无变化或消退相关(p=0.01)。
在我们对未经高分辨率肛门镜检查治疗的大量 HIV 阳性患者队列中,进展率较低。值得注意的是,初次就诊时出现可见病变和 CD4 计数较低与进展相关。肛门湿疣的初始外科病理学与进展相关,而高危血清型与消退或稳定相关。识别危险因素对 HIV 阳性肛门湿疣/肛门发育不良患者的术后监测和咨询具有重要意义。